Evidence package
A target/context table with source dates, perturbation direction, contradictions and missing data.
CRISPR / Project brief
Proposed project · No experimental result claimedFunctional Restoration Pilot
One cell context. One useful function. An explicit decision.
Hypothesis to evaluate
A bounded question before a larger commitment.
A focused comparison of regulated gene activity could identify a reproducible improvement in a relevant cellular function without loss of identity. This is a proposed hypothesis, not a Karam result.
Qualified study scope
Specialist-approved cell model, functional and identity endpoints, independent units, data handover and safety questions.
Feasibility record
If resources and approvals permit, a bounded partner study followed by a documented advance, revise or stop decision.
Capability needed
Aging-biology lead, functional-genomics partner, quantitative analyst and genome-safety expertise.
Reasons to revise or stop
Do not classify increased proliferation, selective loss of damaged cells or escape from protective arrest as restoration. Revisit the hypothesis if specialized function or cell identity is not preserved.
What must be agreed before work begins
An accountable scientific lead, authorized inputs, provider responsibilities, resources, relevant approvals, data handover, interpretation criteria and a written rights position. No named institution is presented as a contracted Karam partner.
The deliverable is not a guaranteed positive finding
A well-explained negative or inconclusive result can satisfy a properly scoped project. Acceptance should be based on the agreed work and evidence, not on a favorable claim.
Source trail
Scientific summaries are adapted from the supplied 15 October 2026 CRISPR Project Assessment. Source records show the original references and review access; this release is not a new systematic review.
C01 — Yin J, Gao Y, Jing Y, et al. CRISPR screening identifies GNPTAB as a noncanonical STING activator driving cellular senescence. Protein & Cell. 27 July 2026.C03 — Plesa AM, Jung S, Wang HH, et al. Transcriptomic reprogramming screen identifies SRSF1 as a regulator of aging. Nature Aging. 14 October 2026;6:2057–2073.C11 — Saroj N, Velangani HG, Kiran S, Dholaniya PS. Deletion of TOP2B promoter using CRISPR-Cas9 induces senescence in HEK 293T cells. Biochemistry and Biophysics Reports. 19 May 2026;46:102620.C12 — Lai C, Fu W, Liu J, et al. LMO7-mediated POLR2A degradation promotes cellular senescence through the MDM4/p53/p21 axis. Cell Death & Disease. 28 March 2026;17:421.Bring the capability that changes the project.
Scientific, analytical and laboratory partners can propose a specific contribution with evidence of their relevant work.